EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieKohortenstudieOpen Access · CC BY 4.0

Sex differences in outcomes of vitamin K antagonist treatment in patients with a mechanical heart valve: a Dutch population-based cohort study

Eva K Kempers, Chantal Visser, Jaap Seelig, Qingui Chen, Henk J Adriaansen, Maarten J Beinema, Arina J Ten Cate-Hoek, Laura M Faber, Charlotte E A Dronkers, Melchior C Nierman, Roger K Schindhelm, Nynke M Wiersma und 10 weitere

Journal of Thrombosis and Haemostasis · 2026

DOI: 10.1016/j.jtha.2025.09.010 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026. Verfasst von Eva K Kempers und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Erasmus Medical Center, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: Vitamin K, Anticoagulants, Thromboembolism, Heart Valve Prosthesis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Roche, ZonMw, Trombosestichting Nederland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Patients with a mechanical heart valve (MHV) require vitamin K antagonist (VKA) treatment to prevent thromboembolism. OBJECTIVES: To examine the quality of VKA treatment and clinical outcomes, including all-cause mortality, bleeding, and thromboembolism, by sex and age in patients with an MHV. METHODS: Data from 17 Dutch anticoagulation clinics were linked to Statistics Netherlands. Patients with an MHV receiving VKAs between 2013 and 2019 were included and followed from the first MHV hospitalization discharge until death, VKA discontinuation, or December 31, 2019. Quality of treatment was assessed by the time in therapeutic range (TTR) and international normalized ratio variability (variance growth rate). Clinical outcomes were identified by first in-hospital diagnoses and primary causes of death and expressed as incidence rates (IR) per 100 person-years, stratified by sex and age. RESULTS: In total, 3527 MHV patients (38% women, median age 67 years) had a median follow-up of 3.0 years. Women

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin KAnticoagulantsThromboembolismHeart Valve ProsthesisHeart Valve Prosthesis ImplantationHumansFemaleMaleNetherlandsAgedMiddle AgedHemorrhageSex FactorsTreatment OutcomeAged, 80 and overRisk FactorsTime FactorsAge FactorsIncidenceAdultInternational Normalized RatioRisk Assessment

Stichwörter der Autor:innen

4-hydroxycoumarinsheart valve prosthesishemorrhageinternational normalized ratiothromboembolism

Substanzen

Vitamin KAnticoagulants

Autor:innen und Institutionen

  • Department of Hematology, Erasmus Medical Center, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Department of Cardiology, Rijnstate, Arnhem, the Netherlands; Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Department of Clinical Epidemiology, Leiden University Medical Centre, Leiden, the Netherlands.
  • Department of Thrombosis and Anticoagulation, Tergooi Medical Center, Hilversum, the Netherlands; Department of Thrombosis and Anticoagulation, Trombosedienst Noord-West Veluwe, Harderwijk, the Netherlands.
  • Medlon Anticoagulation Clinic, Deventer Hospital, Deventer, the Netherlands.
  • Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands; Thrombosis Expertise Center, Heart and Vascular Center, Maastricht University Medical Center, Maastricht, the Netherlands.

Förderung

  • Roche
  • ZonMw
  • Trombosestichting Nederland
  • HORIZON EUROPE Framework Programme
  • Hartstichting

Zitieren

APA

Kempers, E. K., Visser, C., Seelig, J., Chen, Q., Adriaansen, H. J., Beinema, M. J., Ten Cate-Hoek, A. J., Faber, L. M., Dronkers, C. E. A., Nierman, M. C., Schindhelm, R. K., Wiersma, N. M., Stork, A. D. M., Klok, F. A., Leebeek, F. W. G., Pisters, R., Cannegieter, S. C., De Caterina, R., Hemels, M. E. W., …, & Kruip, M. J. H. A. (2026). Sex differences in outcomes of vitamin K antagonist treatment in patients with a mechanical heart valve: a Dutch population-based cohort study. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.09.010

Vancouver

Kempers EK, Visser C, Seelig J, Chen Q, Adriaansen HJ, Beinema MJ, et al. Sex differences in outcomes of vitamin K antagonist treatment in patients with a mechanical heart valve: a Dutch population-based cohort study. Journal of Thrombosis and Haemostasis. 2026. doi:10.1016/j.jtha.2025.09.010

BibTeX
@article{Kempers2026,
  author = {Kempers, Eva K and Visser, Chantal and Seelig, Jaap and Chen, Qingui and Adriaansen, Henk J and Beinema, Maarten J and Ten Cate-Hoek, Arina J and Faber, Laura M and Dronkers, Charlotte E A and Nierman, Melchior C and Schindhelm, Roger K and Wiersma, Nynke M and Stork, Alexander D M and Klok, Frederikus A and Leebeek, Frank W G and Pisters, Ron and Cannegieter, Suzanne C and De Caterina, Raffaele and Hemels, Martin E W and Ten Cate, Hugo and Kavousi, Maryam and Kruip, Marieke J H A},
  title = {Sex differences in outcomes of vitamin K antagonist treatment in patients with a mechanical heart valve: a Dutch population-based cohort study},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2026},
  doi = {10.1016/j.jtha.2025.09.010}
}
Kostenlos starten →